Business & Industry

Donald Trump’s new tariffs when it comes to pharmaceutical imports are not going to apply to countries having negotiated agreements with the U.S. that contain the provisions on drugs, as per a White House official, therefore delivering promised tariff...

After the FDA went on to state that it was taking on what it has understood to be misleading or deceptive direct-to-consumer pharmaceutical ads, the floodgates have gone on to open, and how? In the first few days post the announcement,...

US President Donald Trump is all set to order his health department to go ahead and crack down on direct-to-consumer (D2C) pharmaceutical advertising as per a new memorandum that was inked on September 9, 2025. This push, which happens to...

It is worth noting that the pharmaceutical sector’s recent source of novel molecules may as well be coming under threat. Apparently, it is the White House which is reportedly preparing an executive order that is going to place restrictions...

Building Excellence Through Structured Competency Development The pharmaceutical cold chain industry demands highly skilled professionals who can manage complex temperature-controlled systems while ensuring regulatory compliance and product integrity. Competency frameworks provide structured approaches to developing, assessing, and maintaining the skills...

The Critical Challenge of Pharmaceutical Customs Clearance The pharmaceutical industry faces unprecedented challenges in global supply chain management, particularly when navigating the complex landscape of international customs clearance for clinical trial materials and commercial drug batches. Customs delays can have...

A Drug Master File (DMF) is a confidential regulatory submission that provides comprehensive, precise, and accurate data about an Active Pharmaceutical Ingredient (API) or a Finished Product Dosage Form (FP). It encompasses critical information on the manufacturing process, quality...